相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma
Le Ngoc Ha et al.
CANCER IMAGING (2021)
Updates on the Management of Thyroid Cancer
Katherine A. Araque et al.
HORMONE AND METABOLIC RESEARCH (2020)
Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid Cancer
Kevin J. Donohoe et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Prognostic Value of Pre-Ablation Stimulated Thyroglobulin in Children and Adolescents with Differentiated Thyroid Cancer
Lina Liu et al.
THYROID (2020)
Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?
Kinga Hincza et al.
CANCERS (2020)
Comparison of Survival and Risk Factors of Differentiated Thyroid Cancer in the Geriatric Population
Lujiao Yu et al.
FRONTIERS IN ONCOLOGY (2020)
How Important is the Timing of Radioiodine Ablation in Differentiated Thyroidal Carcinomas: A Referral Centre Experience
F. S. Simsek et al.
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR (2020)
Polymer Nanoformulation of Sorafenib and All-Trans Retinoic Acid for Synergistic Inhibition of Thyroid Cancer
Shijie Li et al.
FRONTIERS IN PHARMACOLOGY (2020)
Lung Metastases From Papillary Thyroid Cancer With Persistently Negative Thyroglobulin and Elevated Thyroglobulin Antibody Levels During Radioactive Iodine Treatment and Follow-Up: Long-Term Outcomes and Prognostic Indicators
Zhong-Ling Qiu et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Clinical, Pathological, and Molecular Characteristics Correlating to the Occurrence of Radioiodine Refractory Differentiated Thyroid Carcinoma: A Systematic Review and Meta-Analysis
Yi Luo et al.
FRONTIERS IN ONCOLOGY (2020)
Prognostic value and dynamics of antithyroglobulin antibodies for differentiated thyroid carcinoma
Danyang Sun et al.
BIOMARKERS IN MEDICINE (2020)
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers
Lara A. Dunn et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
TERT promoter mutation in primary papillary thyroid carcinoma lesions predicts absent or lower 131i uptake in metastases
Zhaowei Meng et al.
IUBMB LIFE (2019)
Impact of tumor-associated macrophages and BRAFV600E mutation on clinical outcomes in patients with various thyroid cancers
Jae Won Cho et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)
Radioiodine refractoriness score: A multivariable prediction model for postoperative radioiodine-refractory differentiated thyroid carcinomas
Genpeng Li et al.
CANCER MEDICINE (2018)
Lung Recurrence of Papillary Thyroid Cancer Diagnosed With Antithyroglobulin Antibodies After 10 Years From Initial Treatment
David Viola et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis
Chen Wang et al.
PLOS ONE (2017)
Generation of a Potential Prognostic Matrix for Papillary Thyroid Cancer that Assesses Age, Tumor Size, Transforming Growth Factor-β, and BRAFV600E Mutation
Ping Wang et al.
ONCOLOGY RESEARCH AND TREATMENT (2017)
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging
Mahul B. Amin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Preablative Stimulated Thyroglobulin Correlates to New Therapy Response System in Differentiated Thyroid Cancer
Xue Yang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Dose-Response Relationship in Differentiated Thyroid Cancer Patients Undergoing Radioiodine Treatment Assessed by Means of 124I PET/CT
Roel Wierts et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen et al.
THYROID (2016)
Thyroglobulin antibody levels do not predict disease status in papillary thyroid cancer
Stephanie Smooke-Praw et al.
CLINICAL ENDOCRINOLOGY (2014)
Thyroglobulin Autoantibodies as Surrogate Biomarkers in the Management of Patients with Differentiated Thyroid Carcinoma
U. Feldt-Rasmussen et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Long-Term Prognosis of Differentiated Thyroid Cancer with Lung Metastasis in Korea and Its Prognostic Factors
Sun Wook Cho et al.
THYROID (2014)
Sequential Changes of Serum Antithyroglobulin Antibody Levels Are a Good Predictor of Disease Activity in Thyroglobulin-Negative Patients with Papillary Thyroid Carcinoma
Ching-Jung Hsieh et al.
THYROID (2014)
New Developments in the Diagnosis and Treatment of Thyroid Cancer
David F. Schneider et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Molecular pathogenesis and mechanisms of thyroid cancer
Mingzhao Xing
NATURE REVIEWS CANCER (2013)
Clinical Utility of Thyroglobulin Antibody (TgAb) Measurements for Patients with Differentiated Thyroid Cancers (DTC)
Carole A. Spencer
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Prognostic Impact of Serum Thyroglobulin Doubling-Time Under Thyrotropin Suppression in Patients with Papillary Thyroid Carcinoma Who Underwent Total Thyroidectomy
Akira Miyauchi et al.
THYROID (2011)
分享论文
